Epidemiology and risk factors for chronic kidney disease

Medical Clinics of North America

Volumn 89, Issue 3, 2005, Pages 419-445

  McClellan, William M ^a,b  

^a EMORY UNIVERSITY   (United States)

^b Georgia Medical Care Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; FAMILY HISTORY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; META ANALYSIS; NONHUMAN; OBESITY; PATIENT EDUCATION; PATIENT MONITORING; POVERTY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN URINE LEVEL; RACE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SMOKING CESSATION; SOCIAL STATUS; UNITED STATES;

EID: 14744293111     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.11.006     Document Type: Review

References (170)

1. US Renal Data System Annual data report: atlas of end-stage renal disease in the United States 2002 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
2. A.J. Collins End-stage renal disease: are we ready for an emerging epidemic? Postgrad Med 108 2000 13 15
3. G. Eknoyan, A.S. Levey, and N.W. Levin The national epidemic of chronic kidney disease: what we know and what we can do Postgrad Med 110 2001 23 29
4. G. Lee End-stage renal disease in the Asian-Pacific region Semin Nephrol 23 2003 107 114
5. B. Stengel, S. Billon, and P.C. Van Dijk Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999 Nephrol Dial Transplant 18 2003 1824 1833
6. V. Sakhuja, and K. Sud End-stage renal disease in India and Pakistan: burden of disease and management issues Kidney Int Suppl 83 2003 S115 S118
7. R.S. Barsoum Overview: end-stage renal disease in the developing world Artif Organs 26 2002 737 746
8. V. Kher End-stage renal disease in developing countries Kidney Int 62 2002 350 362
9. S.J. Rosansky, and K. Jackson Rate of change of end-stage renal disease treatment incidence 1978-1987 - has there been selection? J Am Soc Nephrol 2 1992 1502 1506
10. L.H. Moulton, F.K. Port, and R.A. Wolfe Patterns of low incidence of treated end-stage renal disease among the elderly Am J Kidney Dis 20 1992 55 62
11. A. Russell, P. Remington, and D. D'Alessio Increasing incidence of end-stage renal disease in Wisconsin: an unintended consequence of increased survival? WMJ 100 2001 35 38
12. R.M. Merrill, L.G. Kessler, and J.M. Udler Comparison of risk estimates for selected diseases and causes of death Prev Med 28 1999 179 193
13. B.A. Kiberd, and C.M. Clase Cumulative risk for developing end-stage renal disease in the US population J Am Soc Nephrol 13 2002 1635 1644
14. Statistics CMS. Medicare. Available at: http://www.cms.hhs.gov/Review/ Supp/. Accessed June 2004.
15. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 s1 s266
16. G. Eknoyan Meeting the challenges of the new K/DOQI guidelines Am J Kidney Dis 41 2003 3 10
17. S.S. Patel, P.L. Kimmel, and A. Singh New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI Semin Nephrol 22 2002 449 458
18. N. Levin, G. Eknoyan, and M. Pipp National Kidney Foundation: Dialysis Outcome Quality Initiative. Development of methodology for clinical practice guidelines Nephrol Dial Transplant 12 1997 2060 2063
19. L.H. Diamond, and D.C. Daly Forum of the End-Stage Renal Disease Networks' role in implementing the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines Adv Ren Replace Ther 6 1999 28 35
20. A.J. Collins, T.L. Roberts, and W.L. St Peter United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines Am J Kidney Dis 39 2002 784 795
21. Department of Health Education, and Welfare Healthy people: the Surgeon General's report on health promotion and disease prevention 1979 Public Health Service, US Government Printing Office Washington
22. National Center for Health Statistics Healthy people 2000 final review 2001 Public Health Service Hyattsville (MD)
23. T.H. Hostetter, J.L. Olson, and H.G. Rennke Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation Am J Physiol 241 1981 F85 F93
24. B.M. Brenner, T.W. Meyer, and T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
25. B.M. Brenner, and H.S. Mackenzie Nephron mass as a risk factor for progression of renal disease Kidney Int Suppl 63 1997 S124 S127
26. W.L. St Peter, A.C. Schoolwerth, and T McGowan Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes Am J Kidney Dis 41 2003 903 924
27. C. Roubicek, P. Brunet, and L. Huiart Timing of nephrology referral: influence on mortality and morbidity Am J Kidney Dis 36 2000 35 41
28. P. Arora, G.T. Obrador, and R. Ruthazer Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center J Am Soc Nephrol 10 1999 1281 1286
29. N. Lameire, and W. Van Biesen The pattern of referral of patients with end-stage renal disease to the nephrologist: a European survey Nephrol Dial Transplant 14 Suppl 6 1999 16 23
30. R.J. Schmidt, J.R. Domico, and M.I. Sorkin Early referral and its impact on emergent first dialyses, health care costs, and outcome Am J Kidney Dis 32 1998 278 283
31. J.C. Korevaar, M.A. Jansen, and F.W. Dekker Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. When to initiate dialysis: effect of proposed US guidelines on survival Lancet 358 2001 1046 1050
32. J.C. Korevaar, M.A. Jansen, and F.W. Dekker NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis. Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. National Kidney Foundation-Dialysis Outcomes Quality Initiative Am J Kidney Dis 39 2002 108 115
33. P.A. Ellis, V. Reddy, and N. Bari Late referral of end-stage renal failure QJM 91 1998 727 732
34. O. Ifudu, M. Dawood, and Y. Iofel Delayed referral of black, Hispanic, and older patients with chronic renal failure Am J Kidney Dis 33 1999 728 733
35. M. Sekkarie, M. Cosma, and D. Mendelssohn Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States Am J Kidney Dis 38 2001 36 41
36. A.M. Chesser, and L.R. Baker Temporary vascular access for first dialysis is common, undesirable and usually avoidable Clin Nephrol 51 1999 228 232
37. C.A. Jones, G.M. McQuillan, and J.W. Kusek Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey Am J Kidney Dis 32 1998 992 999 [erratum in: Am J Kidney Dis 2000;35:178]
38. C.M. Clase, A.X. Garg, and B.A. Kiberd Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III) J Am Soc Nephrol 13 2002 1338 1349
39. J. Coresh, B.C. Astor, and T. Greene Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
40. A.X. Garg, B.A. Kiberd, and W.F. Clark Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III Kidney Int 61 2002 2165 2175
41. P. Muntner, J. He, and L. Hamm Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 2002 745 753
42. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
43. H.M. Perry Jr., J.P. Miller, and J.R. Fornoff Early predictors of 15-year end-stage renal disease in hypertensive patients Hypertension 25 1995 587 594
44. M.J. Klag, P.K. Whelton, and B.L. Randall Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18
45. M. Tozawa, K. Iseki, and C. Iseki Blood pressure predicts risk of developing end-stage renal disease in men and women Hypertension 41 2003 1341 1345
46. M.K. Haroun, B.G. Jaar, and S.C. Hoffman Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington county, Maryland J Am Soc Nephrol 14 2003 2934 2941
47. G.L. Bakris, M. Williams, and L. Dworkin Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kidney Dis 36 2000 646 661
48. National High Blood Pressure Education Program Working Group National High Blood Pressure Education Program Working Group report on hypertension in diabetes Hypertension 23 1994 145 158
49. National High Blood Pressure Education Program Working Group 1995 update of the working group reports on chronic renal failure and renovascular hypertension Arch Intern Med 156 1996 1938 1947
50. A.V. Chobanian, G.L. Bakris, and H.R. Black Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
51. H.H. Parving, E. Hommel, and M. Damkjaer Nielsen Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy BMJ 299 1989 533 536
52. G. Maschio, D. Alberti, and G. Janin Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group N Engl J Med 334 1996 939 945
53. G. Viberti, C.E. Mogensen, and L.C. Groop Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group JAMA 271 1994 275 279
54. G.L. Bakris, J.B. Copley, and N. Vicknair Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy Kidney Int 50 1996 1641 1650
55. S. Klahr, A.S. Levey, and G.J. Beck The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884
56. G.L. Bakris, A. Mangrum, and J.B. Copley Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans Hypertension 29 1997 744 750
57. L.A. Hebert, R.P. Bain, and D. Verme Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group Kidney Int 46 1994 1688 1693
58. The GISEN Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Lancet 349 1997 1857 1863
59. R.L. Chaiken, J. Palmisano, and M.E. Norton Interaction of hypertension and diabetes on renal function in black NIDDM subjects Kidney Int 47 1995 1697 1702
60. B.M. Brenner, M.E. Cooper, and D. de Zeeuw RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
61. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
62. J.T. Wright Jr., G. Bakris, and T. Greene African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431
63. T.H. Jafar, P.C. Stark, and C.H. Schmid AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Ann Intern Med 139 2003 244 252
64. B.L. Kasiske, R.S. Kalil, and J.Z. Ma Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis Ann Intern Med 118 1993 129 138
65. A.V. Kshirsagar, M.S. Joy, and S.L. Hogan Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials Am J Kidney Dis 35 2000 695 707
66. Prospective Diabetes Study UK Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes BMJ 352 1998 837 853
67. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
68. The Diabetes Control and Complications (DCCT) Research Group Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial Kidney Int 47 1995 1703 1720
69. Y. Ohkubo, H. Kishikawa, and E. Araki Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28 1995 103 117
70. C. Abraira, J.A. Colwell, and F.Q. Nuttall Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes Diabetes Care 18 1995 1113 1123
71. R. Kawamori, and T. Kamada Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM Jpn J Med 30 1991 618 621
72. American Diabetes Association Nephropathy in diabetes Diabetes Care 27 2004 S79 S83
73. J.P. Matts, J.N. Karnegis, and C.T. Campos Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group J Fam Pract 36 1993 497 503
74. R.J. Anderson, M. O'Brien, and S. MaWhinney Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5 Kidney Int 55 1999 1057 1062
75. M.H. Rubenstein, L.C. Harrell, and B.V. Sheynberg Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102 2000 2966 2972
76. L.A. Szczech, D.N. Reddan, and W.F. Owen Differential survival after coronary revascularization procedures among patients with renal insufficiency Kidney Int 60 2001 292 299
77. L.A. Szczech, P.J. Best, and E. Crowley Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation Circulation 105 2002 2253 2258
78. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
79. P.A. McCullough, S.S. Soman, and S.S. Shah Risks associated with renal dysfunction in patients in the coronary care unit J Am Coll Cardiol 36 2000 679 684
80. R.S. Wright, G.S. Reeder, and C.A. Herzog Acute myocardial infarction and renal dysfunction: a high-risk combination Ann Intern Med 137 2002 563 570
81. M.G. Shlipak, P.A. Heidenreich, and H. Noguchi Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
82. S.E. Reis, M.B. Olson, and L. Fried Mild renal insufficiency is associated with angiographic coronary artery disease in women Circulation 105 2002 2826 2829
83. P.J. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
84. M.G. Shlipak, L.F. Fried, and C. Crump Cardiovascular disease risk status in elderly persons with renal insufficiency Kidney Int 62 2002 997 1004
85. C.R. Walsh, C.J. O'Donnell, and C.A. Camargo Jr. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction Am Heart J 144 2002 1003 1011
86. J. Al Suwaidi, D.N. Reddan, and K. Williams Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980
87. J.L. Januzzi Jr., S.M. Snapinn, and P.M. DiBattiste Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Circulation 105 2002 2361 2366
88. S. Wison, K. Foo, and J. Cunningham Renal function and risk stratification in acute coronary syndromes Am J Cardiol 91 2003 1051 1054
89. M. Tonelli, L. Moye, and F.M. Sacks Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Ann Intern Med 138 2003 98 104
90. R.V. Freeman, R.H. Mehta, and W. Al Badr Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors J Am Coll Cardiol 41 2003 718 724
91. L. Gruberg, N.J. Weissman, and A.D. Pichard Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention Am Heart J 145 2003 529 534
92. H. Reinecke, T. Trey, and F. Matzkies Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions Kidney Int 63 2003 696 701
93. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2 2000 203 210
94. M.T. Kearney, K.A. Fox, and A.J. Lee Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure J Am Coll Cardiol 40 2002 1801 1808
95. N.G. Mahon, E.H. Blackstone, and G.S. Francis The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure J Am Coll Cardiol 40 2002 1106 1113
96. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
97. H.M. Perry Jr., J.P. Miller, and J.R. Fornoff Early predictors of 15-year end-stage renal disease in hypertensive patients Hypertension 25 4 Pt 1 1995 587 594
98. A.J. Bleyer, R. Chen, and R.B. D'Agostino Jr. Clinical correlates of hypertensive end-stage renal disease Am J Kidney Dis 31 1998 28 34
99. W.M. McClellan, R.D. Langston, and R. Presley Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease J Am Soc Nephrol 15 17 2004 1912 1919
100. B.L. Kasiske Relationship between vascular disease and age-associated changes in the human kidney Kidney Int 31 1987 1153 1159
101. L. Bax, Y. van der Graaf, and A.J. Rabelink SMART Study Group. Influence of atherosclerosis on age-related changes in renal size and function Eur J Clin Invest 33 2003 34 40
102. S.M. Smith, W.E. Hoy, and L. Cobb Low incidence of glomerulosclerosis in normal kidneys Arch Pathol Lab Med 113 1989 1253 1255
103. L. Jorgensen, E.J. Nordal, and T.J. Eide The relationship between atherosclerosis of the thoracic aorta and renal scarring in an autopsy material Acta Pathol Microbiol Immunol Scand 93 1985 251 255
104. R. Ferguson, C.E. Grim, and T.J. Opgenorth A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 41 1988 1189 1196
105. B.I. Freedman, J.M. Soucie, and W.M. McClellan Family history of end-stage renal disease among incident dialysis patients J Am Soc Nephrol 8 1997 1942 1945
106. H.H. Lei, T.V. Perneger, and M.J. Klag Familial aggregation of renal disease in a population-based case-control study J Am Soc Nephrol 9 1998 1270 1276
107. D.E. Butkus Familial clustering of end-stage renal disease in Mississippi J Miss State Med Assoc 43 2002 71 77
108. B.J. Spray, N.G. Atassi, and A.B. Tuttle Familial risk, age at onset, and cause of end-stage renal disease in white Americans J Am Soc Nephrol 5 1995 1806 1810
109. D.F. O'Dea, S.W. Murphy, and D. Hefferton Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study Am J Kidney Dis 32 1998 794 801
110. P.G. Van Buynder, J.A. Gaggin, and J.D. Mathews Renal disease patterns in aboriginal Australians: a family-based study in a high incidence community Med J Aust 159 1993 82 87 [erratum in: Med J Aust 1993;159:432]
111. E.P. Queiroz Madeira, O. da Rosa Santos, and S.F. Ferreira Santos Familial aggregation of end-stage kidney disease in Brazil Nephron 91 2002 666 670
112. S. Bergman, B.O. Key, and K.A. Kirk Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease Am J Kidney Dis 27 1996 341 346
113. C. Jurkovitz, H. Franch, and D. Shoham Family members of patients treated for ESRD have high rates of undetected kidney disease Am J Kidney Dis 40 2002 1173 1178
114. S.P. Ramirez, W. McClellan, and F.K. Port Risk factors for proteinuria in a large, multiracial, southeast Asian population J Am Soc Nephrol 13 2002 1907 1917
115. C.F. Thompson, D. Simmons, and J.F. Collins Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus Diabet Med 18 2001 40 46
116. E.R. Seaquist, F.C. Goetz, and S. Rich Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy N Engl J Med 320 1989 1161 1165
117. D.R. McCance, R.L. Hanson, and D.J. Pettitt Diabetic nephropathy: a risk factor for diabetes mellitus in offspring Diabetologia 38 1995 221 226
118. P.P. Faronato, M. Maioli, and G. Tonolo Clustering of albumin excretion rate abnormalities in caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group Diabetologia 40 1997 816 823
119. B.I. Freedman, A.B. Tuttle, and B.J. Spray Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus Am J Kidney Dis 25 1995 710 713
120. L.H. Canani, F. Gerchman, and J.L. Gross Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients Diabetes 48 1999 909 913
121. V. Vijay, C. Snehalatha, and K. Shina Familial aggregation of diabetic kidney disease in type 2 diabetes in south India Diabetes Res Clin Pract 43 1999 167 171
122. P.K. Chandie Shaw, L.A. van Es, and L.C. Paul Renal disease in relatives of Indo-Asian type 2 diabetic patients with end-stage diabetic nephropathy Diabetologia 46 2003 618 624
123. K. Earle, J. Walker, and C. Hill Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy N Engl J Med 326 1992 673 677
124. L.H. Canani, F. Gerchman, and J.L. Gross Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy Diabetes Care 21 1998 1545 1550
125. R.S. Lindsay, J. Little, and A.J. Jaap Diabetic nephropathy is associated with an increased familial risk of stroke Diabetes Care 22 1999 422 425
126. L.G. Hunsicker, S. Adler, and A. Caggiula Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1997 1908 1919
127. J.F. Moorhead, M.K. Chan, and M. El-Nahas Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease Lancet 2 1982 1309 1311
128. B.H. Brouhard, M.D. Cressman, and K.C. Irwin Lipoprotein abnormalities in the progression of renal disease Cleve Clin J Med 57 1990 599 604
129. L.F. Fried, T.J. Orchard, and B.L. Kasiske Effect of lipid reduction on the progression of renal disease: a meta-analysis Kidney Int 59 2001 260 269
130. S.R. Orth, A. Stockmann, and C. Conradt Smoking as a risk factor for end-stage renal failure in men with primary renal disease Kidney Int 54 1998 926 931
131. T. Chuahirun, J. Simoni, and C. Hudson Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes Am J Med Sci 327 2004 57 67
132. H. Schiffl, S.M. Lang, and R. Fischer Stopping smoking slows accelerated progression of renal failure in primary renal disease J Nephrol 15 2002 270 274
133. J.M. Halimi, B. Giraudeau, and S. Vol Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population Kidney Int 58 2000 1285 1292
134. D. Fouque, M. Laville, and J.P. Boissel Controlled low protein diets in chronic renal insufficiency: meta-analysis BMJ 304 1992 216 220
135. D. Fouque, P. Wang, and M. Laville Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure Nephrol Dial Transplant 15 2000 1986 1992
136. B.L. Kasiske, J.D. Lakatua, and J.Z. Ma A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function Am J Kidney Dis 31 1998 954 961
137. M.T. Pedrini, A.S. Levey, and J. Lau The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis Ann Intern Med 124 1996 627 632
138. E.M. Wrone, M.R. Carnethon, and L. Palaniappan Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 580 587
139. E.L. Knight, M.J. Stampfer, and S.E. Hankinson The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency Ann Intern Med 138 2003 460 467
140. B. Stengel, M.E. Tarver-Carr, and N.R. Powe Lifestyle factors, obesity and the risk of chronic kidney disease Epidemiology 14 2003 479 487
141. S. Vupputuri, and D.P. Sandler Lifestyle risk factors and chronic kidney disease Ann Epidemiol 13 2003 712 720
142. C.S. Fox, M.G. Larson, and E.P. Leip Predictors of new-onset kidney disease in a community-based population JAMA 291 2004 844 850
143. M.M. Mitsnefes, P. Khoury, and P.T. McEnery Body mass index and allograft function in pediatric renal transplantation Pediatr Nephrol 17 2002 535 539
144. S.B. Solerte, M. Fioravanti, and N. Schifino Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy Int J Obes 13 1989 203 211
145. A. Chagnac, T. Weinstein, and M. Herman The effects of weight loss on renal function in patients with severe obesity J Am Soc Nephrol 14 2003 1480 1486
146. H. Yokoyama, O. Tomonaga, and M. Hirayama Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients Diabetologia 40 1997 405 411
147. ACE Inhibitors in Diabetic Nephropathy Trialist Group Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin- converting enzyme inhibitors? A meta-analysis of individual patient data Ann Intern Med 134 2001 370 379
148. J.C. Peterson, S. Adler, and J.M. Burkart Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study Ann Intern Med 123 1995 754 762
149. P. Ruggenenti, A. Perna, and L. Mosconi Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) Kidney Int 53 1998 1209 1216
150. L.Y. Agodoa, L. Appel, and G.L. Bakris Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 285 2001 2719 2728
151. C.Y. Hsu, F. Lin, and E. Vittinghoff Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States J Am Soc Nephrol 14 2003 2902 2907
152. M.T. Fullilove Comment: abandoning "race" as a variable in public health research - an idea whose time has come Am J Public Health 88 1998 1297 1298
153. V.M. Mays, N.A. Ponce, and D.L. Washington Classification of race and ethnicity: implications for public health Annu Rev Public Health 24 2003 83 110
154. L. Braun Race, ethnicity, and health: can genetics explain disparities? Perspect Biol Med 45 2002 159 174
155. M.E. Tarver-Carr, N.R. Powe, and M.S. Eberhardt Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors J Am Soc Nephrol 13 2002 2363 2370
156. S.G. Rostand, G. Brown, and K.A. Kirk Renal insufficiency in treated essential hypertension N Engl J Med 320 1989 684 688
157. C.O. Stehman-Breen, D. Gillen, and M. Steffes Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study J Am Soc Nephrol 14 2003 2352 2357
158. J.C. Whittle, P.K. Whelton, and A.J. Seidler Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151 1991 1359 1364
159. F.L. Brancati, J.C. Whittle, and P.K. Whelton The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors JAMA 268 1992 3079 3084
160. T.V. Perneger, P.K. Whelton, and M.J. Klag Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors Arch Intern Med 155 1995 1201 1208
161. F.L. Brancati, P.K. Whelton, and B.L. Randall Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial JAMA 278 1997 2069 2074
162. N.B. Shulman, C.E. Ford, and W.D. Hall Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group Hypertension 13 5 Suppl 1989 I80 I93
163. W.G. Walker, J.D. Neaton, and J.A. Cutler Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. The MRFIT Research Group JAMA 268 1992 3085 3091
164. F. Valderrabano, F. Gomez-Campdera, and E.H. Jones Hypertension as cause of end-stage renal disease: lessons from international registries Kidney Int Suppl 68 1998 S60 S66
165. T. Usami, R. Sato, and A. Yoshida Regional variation in end-stage renal disease Curr Opin Nephrol Hypertens 11 2002 343 346
166. L.H. Moulton, F.K. Port, and R.A. Wolfe Patterns of low incidence of treated end-stage renal disease among the elderly Am J Kidney Dis 20 1992 55 62
167. B. Foxman, L.H. Moulton, and R.A. Wolfe Geographic variation in the incidence of treated end-stage renal disease J Am Soc Nephrol 2 1991 1144 1152
168. E.W. Young, E.A. Mauger, and K.H. Jiang Socioeconomic status and end-stage renal disease in the United States Kidney Int 45 1994 907 911
169. C. Byrne, J. Nedelman, and R.G. Luke Race, socioeconomic status, and the development of end-stage renal disease Am J Kidney Dis 23 1994 16 22
170. N.R. Powe, M.E. Tarver-Carr, and M.S. Eberhardt Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II) Am J Kidney Dis 42 2003 249 255